机构：[1]Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China[2]Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore[3]Center for Reproductive Medicine, Dongguan Maternal And Child Health Care Hospital, Southern Medical University, Dongguan, China[4]Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China深圳市中医院深圳医学信息中心[5]Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China[6]Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China[7]Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, China
National Key Research and Development
Program of China, Grant/Award Number:
2020YFA0908000; National Natural Science
Foundation of China, Grant/Award Numbers:
81702580, 81803456, 81841001, 81903588;
the Fundamental Research Funds for the
Central Public Welfare Research Institutes,
Grant/Award Number: ZXKT18003; the Major
National Science and Technology Program of
China for Innovative Drug,
Grant/Award Number:
2017ZX09101002‐001‐001‐05; TCM One Belt
and One Road Project of CACMS,
Grant/Award Number: GH201807
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|1 区医学
小类|1 区药物化学1 区药学
最新[2025]版：
大类|1 区医学
小类|1 区药物化学1 区药学
第一作者：
第一作者机构：[1]Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China
共同第一作者：
通讯作者：
通讯机构：[1]Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China[3]Center for Reproductive Medicine, Dongguan Maternal And Child Health Care Hospital, Southern Medical University, Dongguan, China[4]Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China[5]Central People's Hospital of Zhanjiang, Zhanjiang, Guangdong, China[6]Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China[7]Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, China[*1]Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China[*2]Center for Reproductive Medicine, Dongguan Maternal And Child Health Care Hospital, Southern Medical University, Dongguan 523000, China[*3]Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China
推荐引用方式(GB/T 7714)：
Meng Yuqing,Ma Nan,Lyu Haining,et al.Recent pharmacological advances in the repurposing of artemisinin drugs.[J].Medicinal research reviews.2021,41(6):3156-3181.doi:10.1002/med.21837.
APA：
Meng Yuqing,Ma Nan,Lyu Haining,Wong Yin Kwan,Zhang Xing...&Wang Jigang.(2021).Recent pharmacological advances in the repurposing of artemisinin drugs..Medicinal research reviews,41,(6)
MLA：
Meng Yuqing,et al."Recent pharmacological advances in the repurposing of artemisinin drugs.".Medicinal research reviews 41..6(2021):3156-3181
：
医学